This inventor holds 1 USPTO granted patent. Top assignee: Syntex (u.s.a.) Inc.. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Andrew John Briggs
Introduction: Andrew John Briggs is a talented inventor based in Mountain View, CA, known for his significant contributions to the field of pharmaceuticals. With a remarkable focus on neuropharmacology, he holds one patent that highlights his innovative spirit and dedication to advancing medical science.
Latest Patents: Andrew's most notable patent, entitled "4-piperazinylindole derivatives with 5-HT6 receptor affinity," demonstrates his commitment to exploring new avenues in the treatment of neurological conditions. This invention reflects his expertise in developing compounds that may have promising therapeutic potential.
Career Highlights: Andrew is currently employed at Syntex (U.S.A.) Inc., a reputable company that focuses on pharmaceutical research and development. His role at Syntex allows him to collaborate with other leading scientists and make pivotal advancements in the industry.
Collaborations: Throughout his career, Andrew has had the opportunity to work alongside esteemed colleagues, including Robin D. Clark and Ralph New Harris, III. These collaborations have not only enriched his research experience but also contributed to the collective efforts in enhancing pharmaceutical innovations.
Conclusion: Andrew John Briggs's journey as an inventor is a testament to the impact of creativity and dedication in the field of science. His patent reflects a bright future for innovations in neuropharmacology, and his collaborations with notable professionals underscore the collaborative nature of scientific advancement.